Department of Neuroscience and Rehabilitation, University Hospital of Ferrara
Ferrara, Emilia-Romagna, 44124, Italy
NCT Number: NCT04637984
Stroke is a worldwide major cause of disability with great social and economic burdens. The recovery of motor function is crucial for the patient to regain independence and quality of life. Identifying early predictors of motor recovery and outcomes is useful for planning personalized rehabilitation programs and increasing their efficiency. However, making predictions using a single clinical assessment is often difficult and a combination of multiple tools is required. In the last decades, were validated two predictive algorithms for upper limb function and independent walking that can be easily implemented into clinical practice with the aim of increasing knowledge on expected outcome after stroke in patients, families and rehabilitation teams. This will be the first single-site randomized control trial that will test the implementation of such tools in a rehabilitation setting in Italy.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Ferrara, Emilia-Romagna, 44124, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A) PREP2. It combines clinical measures and neurological biomarkers in the initial days after stroke: 1) SAFE score (day 3), which is the sum of shoulder abduction and finger extension strength in the paretic upper limb using the Medical Research Council (MRC); 2) NIH Stroke Scale (day 3); 3) transcranial magnetic stimulation (day 3-7) to determine the presence of MEPs in the paretic arm. According with the aforementioned measures, 4 categories of upper limb recovery will be identified: EXCELLENT, GOOD, LIMITED and POOR.
Time frame: Hospital discharge (an average of 3-6 months)
Length of stay as measure of rehabilitation efficiency
Time frame: Baseline, hospital discharge (an average of 3-6 months)
Measure of efficiency of rehabilitation. Assess a patient's level of disability as well as change in patient status in response to rehabilitation.
Time frame: Baseline, hospital discharge (an average of 3-6 months)
Measure of the complexity of rehabilitation needs and/or interventions.
Time frame: Baseline, week 4
Will be assessed tracking: therapists confidence about patients' recovery (0-5 Likert scale); therapy content; therapy duration.
Time frame: week 4, 12, week 26
To assess upper extremity performance (coordination, dexterity and functioning)
Time frame: week 4, 12, week 26
To assess the sensorimotor impairment in individuals who have had stroke.
Time frame: week 4, 12, week 26
To evaluate how stroke has impacted your health and life.
Time frame: week 4, week 12, week 26
EEG data will be recorded with the aim of characterizing the PREP2 recovery classes.
Time frame: week 4, week 12, week 26
EEG data will be recorded with the aim of characterizing the PREP2 recovery classes.
Time frame: week 4, week 12, week 26
Kinematic data of trunk and affected hand will be recorded during subject imitations. Kinematic data will be recorded with the aim of characterizing the PREP2 recovery classes.
Time frame: week 4
Self-report questionnaire using a Visual Analogue Scale (0 - Strongly disagree; 10 - Strongly agree). Higher score indicates greater satisfaction with the treatment.
University Hospital of Ferrara
Other
The Implementation of PREP2 Algorithms Into Clinical Practice: a Strategy for Improving Rehabilitation Efficiency and Clinical Outcomes After Stroke. A Single-site Randomized Control Trial
Acronym: PRESTO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07454655
Brain Diseases, Cardiovascular Diseases
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT07534124
Brain Diseases, Cardiovascular Diseases
Madrid, Spain
View Trial DetailsNCT06501014
Brain Diseases, Cardiovascular Diseases
Konya, Turkey (Türkiye)
View Trial DetailsNCT06937346
Brain Diseases, Cardiovascular Diseases
Karaganda, Kazakhstan
View Trial Details